Matsumoto K, Nakamura T
Department of Biology, Faculty of Science, Kyushu University, Fukuoka, Japan.
Crit Rev Oncog. 1992;3(1-2):27-54.
Hepatocyte growth factor (HGF) is the most potent mitogen for mature hepatocytes and seems to act as a hepatotropic factor that has not been purified over the past 30 years. HGF was first purified from rat platelets in 1986. HGF is a hetrodimer molecule composed of 69-kDa alpha-subunit and 34-beta-subunit. In 1989, cDNAs of both human and rat HGF were cloned and primary structure of HGF was determined. HGF is derived from preproprecursor of of 728 amino acids, which is proteolytically processed to form mature HGF. The alpha-chain contains four kringle domains and it has 38% homology with plasmin. HGF mRNA and HGF activity increase markedly in the liver of rats after various liver injuries such as hepatitis, ischemia, physical crush, and partial hepatectomy. Production of HGF in the liver occurs in Kupffer cells and sinusoidal endothelial cells, but not in parenchymal hepatocytes. HGF mRNA is also markedly increased even in the intact lung, kidney, and spleen after injuries of the liver. Therefore, HGF may act as a trigger for liver regeneration through two mechanisms: a paracrine mechanism and an endocrine mechanism. Moreover, HGF mRNA increases markedly in the kidney after various renal injuries, thus it suggests that HGF may act not only as a hepatotropic factor but also as a renotropic factor. HGF receptor with a Kd of 20 to 30 pM is widely distributed in various epithelial cells including hepatocytes. HGF receptor was recently identified as the product of c-met protooncogene, which encodes a 190-kDa transmembrane protein possessing tyrosine kinase domain. HGF has recently been shown to be a pleiotropic factor. HGF stimulates growth of various epithelial cells, including renal tubular cells (Mitogen). It is worth noting that HGF strongly enhances motility of epithelial cells (Motogen) and induces epithelial tubule formation (Morphogen), while it strongly inhibits growth of several tumor cells. All these findings indicate that HGF may have important roles in organogenesis, morphogenesis, carcinogenesis, as well as in organ regeneration.
肝细胞生长因子(HGF)是成熟肝细胞最有效的促有丝分裂原,似乎作为一种促肝细胞因子,在过去30年里一直未被纯化。1986年,HGF首次从大鼠血小板中纯化出来。HGF是一种异源二聚体分子,由69 kDa的α亚基和34 kDa的β亚基组成。1989年,人类和大鼠HGF的cDNA被克隆,HGF的一级结构得以确定。HGF来源于728个氨基酸的前体前体,经蛋白水解加工形成成熟的HGF。α链包含四个kringle结构域,与纤溶酶有38%的同源性。在各种肝损伤如肝炎、缺血、物理挤压和部分肝切除后,大鼠肝脏中的HGF mRNA和HGF活性显著增加。肝脏中HGF的产生发生在库普弗细胞和窦状内皮细胞中,而实质肝细胞中不产生。即使在肝脏损伤后,完整的肺、肾和脾脏中的HGF mRNA也会显著增加。因此,HGF可能通过旁分泌机制和内分泌机制两种机制作为肝脏再生的触发因素。此外,在各种肾损伤后,肾脏中的HGF mRNA显著增加,因此表明HGF不仅可能作为促肝细胞因子,还可能作为促肾因子。Kd为20至30 pM的HGF受体广泛分布于包括肝细胞在内的各种上皮细胞中。HGF受体最近被确定为c-met原癌基因的产物,该基因编码一种具有酪氨酸激酶结构域的190 kDa跨膜蛋白。HGF最近被证明是一种多效性因子。HGF刺激包括肾小管细胞在内的各种上皮细胞的生长(促有丝分裂原)。值得注意的是,HGF强烈增强上皮细胞的运动性(促运动原)并诱导上皮小管形成(促形态发生原),同时它强烈抑制几种肿瘤细胞的生长。所有这些发现表明,HGF可能在器官发生、形态发生、致癌作用以及器官再生中发挥重要作用。